Inactivation of Brca2 Promotes Trp53-Associated but Inhibits KrasG12D-Dependent Pancreatic Cancer Development in Mice
Open Access
- 30 April 2011
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 140 (4), 1303-1313.e3
- https://doi.org/10.1053/j.gastro.2010.12.039
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trialThe Lancet, 2010
- β-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in miceJCI Insight, 2010
- Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-RasCancer Cell, 2009
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility GeneScience, 2009
- Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial NeoplasiaThe American Journal of Pathology, 2007
- Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerGenes & Development, 2006
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancerGenes & Development, 2003
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988